Shopping Cart

Close

No products in the cart.

LeadR Profile


Barry J A Laird
NHS Lothian
United Kingdom

SLR Oncology ScienceLeadR Reputation 100%

Favorite Settings

Follow this Expert

Health Specialties

Main specialty  Oncology
Full career - Last 3 years

Main Topics

Publications and Clinical Trials


Publications - Clinical Trials

Education

Academic Background

Source: ORCID

Organization

all information about organizations

Source: Pubmed

University of Edinburgh

Cancer Research UK Edinburgh Centre

Western General Hospital

St Columba's Hospice Care

NHS Lothian

MRC Institute of Genetics and Molecular Medicine

Norwegian University of Science and Technology

University of Glasgow

Glasgow Royal Infirmary

Beatson West of Scotland Cancer Centre

Awards and Honors

Source: ORCID

Academic Societies

Source: ORCID

Publications Synthesis

Source: Pubmed

Number : 133

Citations

Citations: 2 642 1st author: 21 Last author: 34 Unique author: 1

Main journals

J Cachexia Sarcopenia Muscle 10
Curr Opin Support Palliat Care 9
BMJ Support Palliat Care 7
Cancers (Basel) 6
J Pain Symptom Manage 6

Best Journals

Ann Oncol 2
Lancet Oncol 1

Breakdown by type

Historic per year



Main pathologies and trends

Publications List

Quick search selection

Source: Pubmed Source: OpenAlex
Title Journal CIT SLR Year
Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints series. J Cachexia Sarcopenia Muscle
38343065
0 8.9 2024
Prognostic value of the Scottish Inflammatory prognostic Score in patients with NSCLC expressing PD-L1 ≥ 50 % progressing on first-line pembrolizumab. Lung Cancer
38295631
0 5.3 2024
Death from COVID-19: management of breathlessness: a retrospective multicentre study. BMJ Support Palliat Care
34711657
1 2.7 2024
Reply to the Letter to the Editor "A simple way of doing the complex but utmost important things: cancer pain management" by S. Singhal, M. Verma and D. Kukreja. Ann Oncol
37121609
0 50.5 2023
The prognostic impact of pre-treatment cachexia in resectional surgery for oesophagogastric cancer: a meta-analysis and meta-regression. Br J Surg
37527401
0 9.6 2023
Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series. J Cachexia Sarcopenia Muscle
37671529
3 8.9 2023
Are CT-Derived Muscle Measurements Prognostic, Independent of Systemic Inflammation, in Good Performance Status Patients with Advanced Cancer? Cancers (Basel)
37444607
0 5.2 2023
The Impact of Acute Systemic Inflammation Secondary to Oesophagectomy and Anastomotic Leak on Computed Tomography Body Composition Analyses. Cancers (Basel)
37174044
0 5.2 2023
The Rise of Supportive Oncology: A Revolution in Cancer Care. Clin Oncol (R Coll Radiol)
36737312
2 3.4 2023
Cancer cachexia - adopting a systems wide approach. Curr Opin Clin Nutr Metab Care
37265093
0 3.1 2023
Top Ten Tips Palliative Care Clinicians Should Know About Cachexia. J Palliat Med
36723498
1 2.8 2023
Longitudinal characterisation of cachexia in patients undergoing surgical resection for cancer. Curr Opin Support Palliat Care
37389614
0 2.1 2023
Cancer cachexia: learn from yesterday, live for today and hope for tomorrow. Curr Opin Support Palliat Care
37499059
0 2.1 2023
Cannabinoids in the treatment of cancer anorexia and cachexia: Where have we been, where are we going? Asia Pac J Oncol Nurs
38197037
1 1.8 2023
Immune-Related Adverse Events, Biomarkers of Systemic Inflammation, and Survival Outcomes in Patients Receiving Pembrolizumab for Non-Small-Cell Lung Cancer. Cancers (Basel)
38067207
0 0 2023
Integrated Short-term Palliative Rehabilitation to improve quality of life and equitable care access in incurable cancer (INSPIRE): a multinational European research project. Palliat Care Soc Pract
37377743
0 0 2023
Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice Guideline. ESMO Open
37087198
0 0 2023
An international, open-label, randomised trial comparing a two-step approach versus the standard three-step approach of the WHO analgesic ladder in patients with cancer. Ann Oncol
36055465
0 50.5 2022
The Obesity Paradox in Cancer: Is Bigger Better? J Cachexia Sarcopenia Muscle
35506563
7 8.9 2022
A systematic review examining the relationship between cytokines and cachexia in incurable cancer. J Cachexia Sarcopenia Muscle
35080147
22 8.9 2022
Cancer cachexia: a nutritional or a systemic inflammatory syndrome? Br J Cancer
35523879
16 8.8 2022
Lactate dehydrogenase: relationship with the diagnostic GLIM criterion for cachexia in patients with advanced cancer. Br J Cancer
36517550
1 8.8 2022
The relationship between frailty, nutritional status, co-morbidity, CT-body composition and systemic inflammation in patients with COVID-19. J Transl Med
35189900
9 7.4 2022
Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer. ESMO Open
35398717
15 6.883 2022
Inflammation and Performance Status: The Cornerstones of Prognosis in Advanced Cancer. J Pain Symptom Manage
36493981
1 4.7 2022
Non-steroidal anti-inflammatory drugs (NSAIDs) in cancer pain: A database analysis to determine recruitment feasibility for a clinical trial. Palliat Med
36113099
0 4.4 2022
Understanding Cancer Cachexia and Its Implications in Upper Gastrointestinal Cancers. Curr Treat Options Oncol
36269458
4 4.3 2022
The prevalence and prognostic value of frailty screening measures in patients undergoing surgery for colorectal cancer: observations from a systematic review. BMC Geriatr
35351011
3 4.1 2022
Optimising Outcomes in Non Small Cell Lung Cancer: Targeting Cancer Cachexia. Front Biosci (Landmark Ed)
35468688
0 3.1 2022
A comparison of CT-body composition measurements in non-cancer and cancer patients from a single UK centre. J Frailty Sarcopenia Falls
36119551
0 0.01 2022
Diagnostic criteria for cancer cachexia: reduced food intake and inflammation predict weight loss and survival in an international, multi-cohort analysis. J Cachexia Sarcopenia Muscle
34448539
18 12.063 2021
Computed tomography-defined low skeletal muscle index and density in cancer patients: observations from a systematic review. J Cachexia Sarcopenia Muscle
34664431
24 12.063 2021
A randomized, feasibility trial of an exercise and nutrition-based rehabilitation programme (ENeRgy) in people with cancer. J Cachexia Sarcopenia Muscle
34612012
11 12.063 2021
ESPEN practical guideline: Clinical Nutrition in cancer. Clin Nutr
33946039
145 7.643 2021
Relationship between cytokines and symptoms in people with incurable cancer: A systematic review. Crit Rev Oncol Hematol
33482344
3 6.625 2021
Power Comparisons and Clinical Meaning of Outcome Measures in Assessing Treatment Effect in Cancer Cachexia: Secondary Analysis From a Randomized Pilot Multimodal Intervention Trial. Front Nutr
33585533
5 6.576 2021
Relation Between Body Composition, Systemic Inflammatory Response, and Clinical Outcomes in Patients Admitted to an Urban Teaching Hospital with COVID-19. J Nutr
34159388
13 4.687 2021
The Emerging Role of Interleukin 1β (IL-1β) in Cancer Cachexia. Inflammation
33907915
13 4.657 2021
The systemic inflammatory response and clinicopathological characteristics in patients admitted to hospital with COVID-19 infection: Comparison of 2 consecutive cohorts. PLoS One
34043668
7 3.752 2021
REVOLUTION (Routine EValuatiOn of people LivIng with caNcer)-Protocol for a prospective characterisation study of patients with incurable cancer. PLoS One
34914733
1 3.752 2021
Use of opioids in patients with cancer with hepatic impairment-a systematic review. BMJ Support Palliat Care
34470772
1 2.7 2021
A biobank analysis of prognostic biomarkers of the systemic inflammatory response in patients presenting with malignancy of undefined primary origin. Eur J Cancer
32947141
3 9.162 2020
Determinants of quality of life in patients with incurable cancer. Cancer
32267548
17 6.86 2020
The Relationship between ECOG-PS, mGPS, BMI/WL Grade and Body Composition and Physical Function in Patients with Advanced Cancer. Cancers (Basel)
32397102
7 6.639 2020
Prognostic factors in patients admitted to an urban teaching hospital with COVID-19 infection. J Transl Med
32933530
29 5.531 2020
Predicting Response to Radiotherapy in Cancer-Induced Bone Pain: Cytokines as a Potential Biomarker? Clin Oncol (R Coll Radiol)
32284199
4 4.126 2020
Percutaneous cervical cordotomy for cancer-related pain: national data (response to letter by Professor S Mercadante). BMJ Support Palliat Care
32680892
0 3.568 2020
Percutaneous cervical cordotomy for cancer-related pain: national data. BMJ Support Palliat Care
32220943
0 3.568 2020
Bayesian methods in palliative care research: cancer-induced bone pain. BMJ Support Palliat Care
32139358
1 2.7 2020
Editorial: Cancer cachexia - bridging the gap. Curr Opin Support Palliat Care
33181606
0 2.302 2020
Comparison of the prognostic value of MUST, ECOG-PS, mGPS and CT derived body composition analysis in patients with advanced lung cancer. Clin Nutr ESPEN
33183562
6 2.234 2020
The relationship between the BMI-adjusted weight loss grading system and quality of life in patients with incurable cancer. J Cachexia Sarcopenia Muscle
31692296
12 12.91 2019
Comparison of the prognostic value of ECOG-PS, mGPS and BMI/WL: Implications for a clinically important framework in the assessment and treatment of advanced cancer. Clin Nutr
31926762
15 7.324 2019
Deterioration in Muscle Mass and Physical Function Differs According to Weight Loss History in Cancer Cachexia. Cancers (Basel)
31816924
11 6.126 2019
The Relationship between Imaging-Based Body Composition Analysis and the Systemic Inflammatory Response in Patients with Cancer: A Systematic Review. Cancers (Basel)
31487957
25 6.126 2019
"How Long Have I Got?"-A Prospective Cohort Study Comparing Validated Prognostic Factors for Use in Patients with Advanced Cancer. Oncologist
30975922
13 5.025 2019
Pain management in patients with malignant mesothelioma: challenges and solutions. Lung Cancer (Auckl)
31037036
1 4.195 2019
Combining optimal nutrition and exercise in a multimodal approach for patients with active cancer and risk for losing weight: Rationale and practical approach. Nutrition
31470259
4 3.769 2019
A systematic review examining nutrition support interventions in patients with incurable cancer. Support Care Cancer
31359182
16 3.603 2019
Combined exercise and nutritional rehabilitation in outpatients with incurable cancer: a systematic review. Support Care Cancer
30944994
19 2.635 2019
Relief of Neuropathic Pain Through Epidermal Growth Factor Receptor Inhibition: A Randomized Proof-of-Concept Trial. Pain Med
31106835
12 2.513 2019
A prospective study examining cachexia predictors in patients with incurable cancer. BMC Palliat Care
31164115
9 2.015 2019
Meaningful measures in cancer cachexia: implications for practice and research. Curr Opin Support Palliat Care
31599817
1 1.618 2019
Editorial: Merging therapeutics and supportive care: synergy and yield. Curr Opin Support Palliat Care
31644452
0 1.618 2019
An exploratory study examining the relationship between performance status and systemic inflammation frameworks and cytokine profiles in patients with advanced cancer. Medicine (Baltimore)
31517821
5 1.552 2019
Oral Ketamine vs Placebo in Patients With Cancer-Related Neuropathic Pain: A Randomized Clinical Trial. JAMA Oncol
29621378
12 22.416 2018
European Society for Medical Oncology (ESMO) position paper on supportive and palliative care. Ann Oncol
29253069
79 14.196 2018
A systematic review examining clinical markers and biomarkers of analgesic response to radiotherapy for cancer-induced bone pain. Crit Rev Oncol Hematol
30661656
4 5.833 2018
The prognostic value of the systemic inflammatory response in randomised clinical trials in cancer: A systematic review. Crit Rev Oncol Hematol
30447918
51 5.012 2018
Cancer cachexia: rationale for the MENAC (Multimodal-Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial. BMJ Support Palliat Care
29440149
69 3.208 2018
The Palliative Radiotherapy and Inflammation Study (PRAIS) - protocol for a longitudinal observational multicenter study on patients with cancer induced bone pain. BMC Palliat Care
30266081
7 2.922 2018
The Management of Opioid-Induced Nausea and Vomiting in Patients with Cancer: A Systematic Review. J Palliat Med
30239277
10 2.238 2018
'The shoulders, clavicles, chest and thighs melt away': a compilation of reviews on cachexia. Curr Opin Support Palliat Care
30300156
0 1.916 2018
Targeting IL-1α in cancer cachexia: a narrative review. Curr Opin Support Palliat Care
30300155
19 1.916 2018
Endpoints in clinical trials in cancer cachexia: where to start? Curr Opin Support Palliat Care
30299325
12 1.916 2018
A randomised, phase II, unblinded trial of an Exercise and Nutrition-based Rehabilitation programme (ENeRgy) versus standard care in patients with cancer: feasibility trial protocol. Pilot Feasibility Stud
30607255
5 0 2018
Treating cancer cachexia: an evolving landscape. Ann Oncol
28911073
6 13.926 2017
The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis. J Cachexia Sarcopenia Muscle
28627024
30 12.511 2017
A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer. J Cachexia Sarcopenia Muscle
28614627
115 12.511 2017
The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: Systematic review and meta-analysis. Crit Rev Oncol Hematol
28693795
110 4.495 2017
Corrigendum to "Prognosis in advanced lung cancer - A prospective study examining key clinicopathological factors" [Lung Cancer 88 (2015) 304-309]. Lung Cancer
28457608
1 4.486 2017
Prognostic Tools in Patients With Advanced Cancer: A Systematic Review. J Pain Symptom Manage
28062344
51 3.249 2017
The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer. PLoS One
28542626
37 2.992 2017
A cross-sectional study examining the prevalence of cachexia and areas of unmet need in patients with cancer. Support Care Cancer
29274028
20 2.754 2017
SYSTEMS-2: A randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma. Clin Transl Radiat Oncol
29594241
8 0 2017
Quality of Life in Patients With Advanced Cancer: Differential Association With Performance Status and Systemic Inflammatory Response. J Clin Oncol
27354484
51 24.008 2016
ESPEN guidelines on nutrition in cancer patients. Clin Nutr
27637832
604 5.496 2016
Does chemotherapy improve health-related quality of life in advanced pancreatic cancer? A systematic review. Crit Rev Oncol Hematol
26819138
22 4.971 2016
Characteristics of the case mix, organisation and delivery in cancer palliative care: a challenge for good-quality research. BMJ Support Palliat Care
27246166
11 3.208 2016
Pain in Malignant Pleural Mesothelioma: A Prospective Characterization Study. Pain Med
27117437
7 2.82 2016
The use of opioids in cancer patients with renal impairment-a systematic review. Support Care Cancer
27744535
12 2.676 2016
Attenuating pain flare: a new role for an old therapy? Lancet Oncol
26489388
0 33.9 2015
Randomized Double-Blind Trial of Pregabalin Versus Placebo in Conjunction With Palliative Radiotherapy for Cancer-Induced Bone Pain. J Clin Oncol
26644535
18 24.008 2015
Is Radiotherapy Useful for Treating Pain in Mesothelioma?: A Phase II Trial. J Thorac Oncol
25654216
21 6.595 2015
Epidermal growth factor receptor-inhibition (EGFR-I) in the treatment of neuropathic pain. Br J Anaesth
26475804
25 6.238 2015
Prognosis in advanced lung cancer--A prospective study examining key clinicopathological factors. Lung Cancer
25870155
53 4.294 2015
Symptom Control Trials in Patients With Advanced Cancer: A Qualitative Study. J Pain Symptom Manage
26031710
12 2.905 2015
A systematic review of opioid effects on the hypogonadal axis of cancer patients. Support Care Cancer
24633592
3 2.698 2014
Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system. Clin Cancer Res
23938289
80 9.619 2013
Confirming neuropathic pain in cancer patients: applying the NeuPSIG grading system in clinical practice and clinical research. Pain
24275256
7 5.445 2013
The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancer. Oncologist
23966223
51 4.54 2013
The characteristics of physical activity and gait in patients receiving radiotherapy in cancer induced bone pain. Radiother Oncol
24231246
3 4.328 2013
Radiotherapy for the treatment of pain in malignant pleural mesothelioma: a systematic review. Lung Cancer
24314815
10 4.294 2013
Pregabalin for the management of neuropathic pain in adults with cancer: a systematic review of the literature. Pain Med
23915361
12 2.82 2013
Prevalence and natural history of pain in adults with multiple sclerosis: systematic review and meta-analysis. Pain
23318126
77 5.445 2012
Quantitative Sensory Testing to assess the sensory characteristics of cancer-induced bone pain after radiotherapy and potential clinical biomarkers of response. Eur J Pain
21658980
17 3.019 2012
Prognostication in advanced cancer: a study examining an inflammation-based score. J Pain Symptom Manage
22732417
8 2.905 2012
Evidence base for multimodal therapy in cachexia. Curr Opin Support Palliat Care
23111703
14 2.045 2012
Clinical management of pain in advanced lung cancer. Clin Med Insights Oncol
23115483
19 0 2012
A systematic review of combination step III opioid therapy in cancer pain: an EPCRC opioid guideline project. Palliat Med
21708862
6 4.22 2011
Mechanisms of cancer-induced bone pain. Clin Oncol (R Coll Radiol)
21683564
33 3.236 2011
Pain, depression, and fatigue as a symptom cluster in advanced cancer. J Pain Symptom Manage
21402467
58 2.905 2011
Cancer pain and its relationship to systemic inflammation: an exploratory study. Pain
21159432
20 5.445 2010
Characterization of cancer-induced bone pain: an exploratory study. Support Care Cancer
20680354
22 2.698 2010
Allogeneic adsorptions: a comparison of the traditional method with a modified PEG adsorption method. Immunohematology
21214296
0 0.27 2010
Are cancer pain and depression interdependent? A systematic review. Psychooncology
18942659
35 3.095 2009
A systematic review examining the literature on attitudes of patients with advanced cancer toward research. J Pain Symptom Manage
19419837
12 2.905 2009
Management of cancer pain: basic principles and neuropathic cancer pain. Eur J Cancer
18439818
25 6.029 2008
Letter to editor: an observational study of red cell transfusion in specialist palliative care. Palliat Med
18718992
2 4.22 2008
Palliative care in the elderly breast cancer patient. Clin Oncol (R Coll Radiol)
19070470
0 3.236 2008
Methadone titration: still no gauge on the tank. Palliat Med
16295293
0 4.22 2005
Hammers and nails: a report. Palliat Med
15623171
1 4.22 2004
What works. Documents on demand. Health Manag Technol
11213619
0 0 2001
Direct calculation of the hard-sphere crystal /Melt interfacial free energy Phys Rev Lett
11082643
5 8.462 2000
Assessing salivary cortisol in studies of child development. Child Dev
9914636
88 4.195 1998
Simulation of the binary hard-sphere crystal/melt interface. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics
9965942
0 0 1996
Instantaneous normal modes and the glass transition. Phys Rev Lett
10058886
5 8.462 1995
Localized low-frequency vibrational modes in a simple model glass. Phys Rev Lett
10043860
4 8.462 1991
Localized low-frequency vibrational modes in glasses. Phys Rev B Condens Matter
9998549
3 0 1991
Freezing of soft spheres: A critical test for weighted-density-functional theories. Phys Rev A
9904592
0 0 1990
Comparison of weighted-density-functional theories for inhomogeneous liquids. Phys Rev A
9904591
0 0 1990
Food intake by Patient-Generated Subjective Global Assessment (PG-SGA) corresponds to energy and protein intake as well as weight change in patients with advanced cancer Clinical Nutrition Experimental
W2932362020
3 0.01 2019

Clinical Trials 8 Source:  ClinicalTrials

Synthesis

Principal Investigator: 2

By phase:

N/A 5
Phase 3 2
Phase 2 1

By status:

Completed 4
Active, not recruiting 2
Recruiting 1
Unknown status 1

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 3
multicentric5to9 0
multicentricup10 1

Main Topics

Nutritional and Metabolic Diseases 3
Nervous System Diseases 2

Cohort/Consortium Investigators 0

Drugs and Sponsors Source: ClinicalTrials

All Clinical Trials information

Clinical Trials Breakdown information Source: ClinicalTrials

Breakdown by Phase

Breakdown by Status

Breakdown by Mono/Multi Centric

Percentage of internationnal

Clinical Trials Timeline Source: ClinicalTrials

Studies Phases and Years

Clinical Trials List Source: ClinicalTrials

Quick search selection

NCTID - Title Phase Status Year

NCT04406662

Routine Evaluation of People Living With Cancer
N/A Recruiting 2020

NCT04484545

Prognostic Factors in Patients Admitted to an Urban Teaching Hospital With COVID 19 Infection
N/A Active, not recruiting 2020

NCT02490436

Novel Treatment Option for Neuropathic Pain
Phase 2 Completed 2015

NCT02330926

Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy
Phase 3 Active, not recruiting 2015

NCT02107664

The Palliative Radiotherapy And Inflammation Study PRAIS
N/A Completed 2013

NCT01419145

A Feasibility Study of Multimodal Exercise Nutrition Anti inflammatory Treatment for Cachexia the Pre MENAC Study
N/A Completed 2011

NCT01362816

The European Palliative Care Cancer Symptom Study (EPCCS)
N/A Completed 2011

NCT01316744

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain
Phase 3 Unknown status 2009

LeadR Networks Source: Pubmed Source: ClinicalTrials

Main global connection map



Nb Contacts:
Country Contact count
United Kingdom 118
Norway 30
United States 20
Ireland 12
Italy 11
Australia 9
Belgium 8
Canada 7
France 7
Brazil 5
Germany 5
Spain 4
Sweden 4
Switzerland 4
Denmark 3
Greece 2
Chile 1
India 1
Japan 1
Mexico 1
Uganda 1

LeadR Networks Source: Pubmed Source: ClinicalTrials

Graph connection

LeadR Networks Source: Pubmed Source: ClinicalTrials

Connection list

Name Organization Country Linked
Fallon Marie University of Edinburgh United Kingdom 56
Mc Millan Donald C University of Glasgow United Kingdom 35
Dolan Ross D University of Glasgow United Kingdom 26
Kaasa Stein Oslo University Hospital Norway 22
Solheim Tora S St Olav's University Hospital Norway 19
Skipworth Richard J E NHS Lothian United Kingdom 17
Simmons Claribel MRC Institute of Genetics and Molecular Medicine United Kingdom 11
Colvin Lesley A Ninewells Hospital United Kingdom 10
Balstad Trude R Norwegian University of Science and Technology Norway 10
Mc Govern Josh University of Glasgow United Kingdom 10
Klepstad Pål St Olav's University Hospital Norway 9
Maddocks Matthew King's College London United Kingdom 9
Sande Tonje A MRC Institute of Genetics and Molecular Medicine United Kingdom 8
Horgan Paul G University of Glasgow United Kingdom 7
Maguire Donogh University of Glasgow United Kingdom 7
Baracos Vickie E Cross Cancer Institute Canada 6
Hjermstad Marianne Jensen Oslo University Hospital Norway 6
Strasser Florian University of Bern Switzerland 6
Wilcock Andrew Nottingham University Hospitals NHS Trust United Kingdom 6
Stene Guro B Senter for Krisepsykologi Norway 6
Sim Wei University of Glasgow United Kingdom 6
Vagnildhaug Ola Magne St Olav's University Hospital Norway 6
Daly Louise University College Cork Ireland 6
Murray Gordon D University of Edinburgh United Kingdom 6
Caraceni Augusto Fondazione IRCCS Istituto Nazionale dei Tumori Italy 5